HER2 Support Group Forums - View Single Post - Lactylation drives tumor progression and immune evasion in triple negative breast can

News · 08-18-2025, 04:57 AM

Breast cancer maintains its position as the most prevalent malignancy in women worldwide, with triple-negative breast cancer (TNBC) representing the most treatment-resistant subtype due to limited therapeutic targets and frequent relapse.

More...

08-18-2025, 04:57 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,052	Lactylation drives tumor progression and immune evasion in triple negative breast can Breast cancer maintains its position as the most prevalent malignancy in women worldwide, with triple-negative breast cancer (TNBC) representing the most treatment-resistant subtype due to limited therapeutic targets and frequent relapse. More...